. Author manuscript; available in PMC: 2023 Jun 1.

Published in final edited form as: HPB (Oxford). 2021 Nov 10;24(6):942–949. doi: 10.1016/j.hpb.2021.11.001

Table 3.

Recurrence^a and overall survival among patients who underwent R0 resection^b

	No TP Biopsy	TP Biopsy	Total
	n = 84	n = 14	n = 98
Recurrence
Any recurrence	16 (19.0%)	2 (14.3%)	18 (18.4%)
PM as site of first recurrence	5 (6.0%)	1 (7.1%)	6 (6.1%)
Overall Survival, median in months (range)	48.9 (17– 248)	41 (7– 91)	57 (7– 248)

TP = transperitoneal biopsy; PM = peritoneal metastasis.

Over a mean interval of 37 months.

Sample sizes too small for statistical or formal comparisons.